Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan
Abstract Objective An increased prevalence of psychiatric comorbidities (including depression and anxiety disorder) has been observed among patients with chronic fatigue syndrome (CFS). However, few studies have examined the presence of depression and anxiety disorder before the diagnosis of CFS. Th...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-02-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12967-023-03886-1 |
_version_ | 1811165761835630592 |
---|---|
author | Chi Chen Hei-Tung Yip Kam-Hang Leong Wei-Cheng Yao Chung-Lieh Hung Ching-Huang Su Chien-Feng Kuo Shin-Yi Tsai |
author_facet | Chi Chen Hei-Tung Yip Kam-Hang Leong Wei-Cheng Yao Chung-Lieh Hung Ching-Huang Su Chien-Feng Kuo Shin-Yi Tsai |
author_sort | Chi Chen |
collection | DOAJ |
description | Abstract Objective An increased prevalence of psychiatric comorbidities (including depression and anxiety disorder) has been observed among patients with chronic fatigue syndrome (CFS). However, few studies have examined the presence of depression and anxiety disorder before the diagnosis of CFS. This study aimed to clarify the preexisting comorbidities and treatments associated with patients with subsequent CFS diagnosis in a population-based cohort in Taiwan. Methods An analysis utilizing the National Health Insurance Research Database of Taiwan was conducted. Participants included were 6303 patients with CFS newly diagnosed between 2000 and 2010 and 6303 age-/sex-matched controls. Results Compared with the control group, the CFS group had a higher prevalence of depression and anxiety disorder before the diagnosis of CFS. Sampled patients who took specific types of antidepressants, namely, selective serotonin reuptake inhibitors (adjusted odds ratio [aOR] = 1.21, 95% confidence interval [CI] 1.04–1.39), serotonin antagonists and reuptake inhibitors (SARI; aOR = 1.87, 95% CI 1.59–2.19), and tricyclic antidepressants (aOR = 1.46, 95% CI 1.09–1.95), had an increased risk of CFS. CFS risk was also higher among participants taking benzodiazepine, muscle relaxants, and analgesic drugs. A sub-group analysis revealed that SARI use was related to an increased risk of CFS in the depression, anxiety disorder, male, and female groups. In the depression and anxiety disorder groups, analgesic drug use was associated with an increased CFS risk. Nonpharmacological treatment administration differed between men and women. Conclusion This population-based retrospective cohort study revealed an increased risk of CFS among populations with preexisting depression and anxiety disorder, especially those taking SARI and analgesic drugs. |
first_indexed | 2024-04-10T15:41:51Z |
format | Article |
id | doaj.art-3b2b329a0a8249d3b173be580cd24ff7 |
institution | Directory Open Access Journal |
issn | 1479-5876 |
language | English |
last_indexed | 2024-04-10T15:41:51Z |
publishDate | 2023-02-01 |
publisher | BMC |
record_format | Article |
series | Journal of Translational Medicine |
spelling | doaj.art-3b2b329a0a8249d3b173be580cd24ff72023-02-12T12:20:55ZengBMCJournal of Translational Medicine1479-58762023-02-0121112310.1186/s12967-023-03886-1Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in TaiwanChi Chen0Hei-Tung Yip1Kam-Hang Leong2Wei-Cheng Yao3Chung-Lieh Hung4Ching-Huang Su5Chien-Feng Kuo6Shin-Yi Tsai7Department of Psychiatry, National Taiwan University HospitalManagement Office for Health Data, China Medical University HospitalDepartment of Medicine, MacKay Medical CollegeDepartment of Anesthesiology and Pain Medicine, Min-Sheng General HospitalInstitute of Biomedical Sciences, MacKay Medical CollegeDepartment of Laboratory Medicine, MacKay Memorial HospitalDepartment of Medicine, MacKay Medical CollegeDepartment of Medicine, MacKay Medical CollegeAbstract Objective An increased prevalence of psychiatric comorbidities (including depression and anxiety disorder) has been observed among patients with chronic fatigue syndrome (CFS). However, few studies have examined the presence of depression and anxiety disorder before the diagnosis of CFS. This study aimed to clarify the preexisting comorbidities and treatments associated with patients with subsequent CFS diagnosis in a population-based cohort in Taiwan. Methods An analysis utilizing the National Health Insurance Research Database of Taiwan was conducted. Participants included were 6303 patients with CFS newly diagnosed between 2000 and 2010 and 6303 age-/sex-matched controls. Results Compared with the control group, the CFS group had a higher prevalence of depression and anxiety disorder before the diagnosis of CFS. Sampled patients who took specific types of antidepressants, namely, selective serotonin reuptake inhibitors (adjusted odds ratio [aOR] = 1.21, 95% confidence interval [CI] 1.04–1.39), serotonin antagonists and reuptake inhibitors (SARI; aOR = 1.87, 95% CI 1.59–2.19), and tricyclic antidepressants (aOR = 1.46, 95% CI 1.09–1.95), had an increased risk of CFS. CFS risk was also higher among participants taking benzodiazepine, muscle relaxants, and analgesic drugs. A sub-group analysis revealed that SARI use was related to an increased risk of CFS in the depression, anxiety disorder, male, and female groups. In the depression and anxiety disorder groups, analgesic drug use was associated with an increased CFS risk. Nonpharmacological treatment administration differed between men and women. Conclusion This population-based retrospective cohort study revealed an increased risk of CFS among populations with preexisting depression and anxiety disorder, especially those taking SARI and analgesic drugs.https://doi.org/10.1186/s12967-023-03886-1Chronic fatigue syndromeDepressionAnxietyPharmacological treatment |
spellingShingle | Chi Chen Hei-Tung Yip Kam-Hang Leong Wei-Cheng Yao Chung-Lieh Hung Ching-Huang Su Chien-Feng Kuo Shin-Yi Tsai Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan Journal of Translational Medicine Chronic fatigue syndrome Depression Anxiety Pharmacological treatment |
title | Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan |
title_full | Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan |
title_fullStr | Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan |
title_full_unstemmed | Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan |
title_short | Presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome: a population-based study in Taiwan |
title_sort | presence of depression and anxiety with distinct patterns of pharmacological treatments before the diagnosis of chronic fatigue syndrome a population based study in taiwan |
topic | Chronic fatigue syndrome Depression Anxiety Pharmacological treatment |
url | https://doi.org/10.1186/s12967-023-03886-1 |
work_keys_str_mv | AT chichen presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan AT heitungyip presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan AT kamhangleong presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan AT weichengyao presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan AT chungliehhung presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan AT chinghuangsu presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan AT chienfengkuo presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan AT shinyitsai presenceofdepressionandanxietywithdistinctpatternsofpharmacologicaltreatmentsbeforethediagnosisofchronicfatiguesyndromeapopulationbasedstudyintaiwan |